Feraheme: Clinical Trials

9 trials of Feraheme, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 1 terminated, 1 unknown. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 4, Recruiting 3, Terminated 1, Unknown 1

Follow Feraheme: new trials by email Literature Review of Feraheme trials Research Report on Feraheme

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Biospecimen Collection, Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Diffusion-Relaxation Correlation Spectrum Imaging - Glioblastoma
Phase 3RecruitingJonsson Comprehensive Cancer Center152025-10-272026-03-10
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
ferumoxytol, Iron sucrose - Iron Deficiency Anemia
Phase 3RecruitingAMAG Pharmaceuticals, Inc.752019-09-182026-04-17
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Ferumoxytol, Iron sucrose - Chronic Kidney Disease; Iron Deficiency Anemia
Phase 3RecruitingAMAG Pharmaceuticals, Inc.1292018-08-132026-04-17
Ferumoxytol-enhanced Magnetic Resonance Imaging
ferumoxytol - Coronary Artery Disease
Phase 3UnknownBrigham and Women's Hospital1852017-02-012023-01-04
A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Ferumoxytol, FCM - Iron Deficiency Anemia
Phase 3CompletedAMAG Pharmaceuticals, Inc.20142016-02-292023-07-25
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
Ferumoxytol - Iron Deficiency Anemia
Phase 3TerminatedAMAG Pharmaceuticals, Inc.82011-12-272022-04-28
A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
Ferumoxytol, Iron Sucrose - Iron Deficiency Anemia
Phase 3CompletedAMAG Pharmaceuticals, Inc.6052010-08-102022-04-21
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
Ferumoxytol - Iron Deficiency Anemia
Phase 3CompletedAMAG Pharmaceuticals, Inc.6342010-07-272022-04-21
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
Ferumoxytol, Placebo - Iron Deficiency Anemia
Phase 3CompletedAMAG Pharmaceuticals, Inc.8122010-06-192022-04-21

Conditions studied

Anemia, Iron-Deficiency (7)  ·  Renal Insufficiency, Chronic (2)  ·  Anemia (1)  ·  Coronary Artery Disease (1)  ·  Glioblastoma (1)

Sponsors

AMAG Pharmaceuticals, Inc. (7)  ·  Brigham and Women's Hospital (1)  ·  Jonsson Comprehensive Cancer Center (1)

Countries

United States (8)  ·  Poland (6)  ·  Hungary (5)  ·  Latvia (4)  ·  Lithuania (4)  ·  Canada (3)  ·  India (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  South Africa (1)

Top investigators

Jingwen Yao (1)

Results publications

PMID 29248659, PMID 30518682

NIH funding

KL2TR001882 (1)